Dendritic cell‐targeted delivery of antigens using extracellular vesicles for anti‐cancer immunotherapy
Cell Proliferation · 2024-07 · 57 (7)
DOI: 10.1111/cpr.13622 ↗At a glance
Journal article in Cell Proliferation, published online on 2024-03-20. Written by Xuan T T Dang and 7 co-authors. Institution: Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Major MEDLINE topics: Dendritic Cells, Extracellular Vesicles, Immunotherapy, Cancer Vaccines. Cited 23 times so far (Crossref); 38 references. The full text is freely available (open access, CC BY 4.0). Funded by: National University of Singapore, Ministry of Health, Singapore, Carmine Therapeutics collaboration grant.
Abstract (original language)
Neoantigen delivery using extracellular vesicles (EVs) has gained extensive interest in recent years. EVs derived from tumour cells or immune cells have been used to deliver tumour antigens or antitumor stimulation signals. However, potential DNA contamination from the host cell and the cost of large‐scale EV production hinder their therapeutic applications in clinical settings. Here, we develop an antigen delivery platform for cancer vaccines from red blood cell‐derived EVs (RBCEVs) targeting splenic DEC‐205 + dendritic cells (DCs) to boost the antitumor effect. By loading ovalbumin (OVA) protein onto RBCEVs and delivering the protein to DCs, we were able to stimulate and present antigenic OVA peptide onto major histocompatibility complex (MHC) class I, subsequently priming activated antigen‐reactive T cells. Importantly, targeted delivery of OVA using RBCEVs engineered with anti‐DEC‐205 antibody robustly enhanced antigen presentation of DCs and T cell activation. This platform is potentially useful for producing personalised cancer vaccines in clinical settings.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Institute for Digital Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- School of Applied Science, Republic Polytechnic, Woodlands, Singapore.
- Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Infectious Disease Translational Research Program, National University of Singapore, Singapore, Singapore.
- Immunology Programme, National University of Singapore, Singapore, Singapore.
ORCID profiles: Minh T N Le
Funding
- National University of Singapore
- Ministry of Health, Singapore
- Carmine Therapeutics collaboration grant
Cite
APA
Dang, X. T. T., Phung, C. D., Lim, C. M. H., Jayasinghe, M. K., Ang, J., Tran, T., Schwarz, H., & Le, M. T. N. (2024). Dendritic cell‐targeted delivery of antigens using extracellular vesicles for anti‐cancer immunotherapy. Cell Proliferation, 57(7). https://doi.org/10.1111/cpr.13622
Vancouver
Dang XTT, Phung CD, Lim CMH, Jayasinghe MK, Ang J, Tran T, et al. Dendritic cell‐targeted delivery of antigens using extracellular vesicles for anti‐cancer immunotherapy. Cell Proliferation. 2024;57(7). doi:10.1111/cpr.13622
BibTeX
@article{Dang2024,
author = {Dang, Xuan T T and Phung, Cao Dai and Lim, Claudine Ming Hui and Jayasinghe, Migara Kavishka and Ang, Jorgen and Tran, Thai and Schwarz, Herbert and Le, Minh T N},
title = {Dendritic cell‐targeted delivery of antigens using extracellular vesicles for anti‐cancer immunotherapy},
journal = {Cell Proliferation},
year = {2024},
volume = {57},
number = {7},
doi = {10.1111/cpr.13622}
}
EUVIMED